ARCHIVES

Investigators Testing Ways To Overcome Gleevec Resistance: High Dose, New Drugs

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

AACR Urges FDA to Regulate High Risk Lab-Developed Tests

September 12, 2014

Nature Editorial Criticizes NCI PR Spending

March 15, 2013

NCI plans 11-16 percent budget cuts in new grants to maintain R01 payline at 20th percentile.

November 28, 2003

Senate Bill Would Require Clinical Trials To Test Gender, Racial Differences In Therapies

August 10, 1990

GAO Report Refutes Charges Against Control Program

May 30, 1980

DRCCA Bard Group Recommends No New Nationwide Screening Program Until More Research Is Done

November 5, 1982